Soliton Inc
  • Clinicians
  • Patients
  • RAP
  • Trials
  • Standards
  • About
  • Investors
  • News
  • Sign-Up

Press Releases

Investors
  • Overview
  • News / Events
    • Overview
    • Press Releases
    • In The News
    • IR Calendar
  • Company Info
    • Overview
    • Presentations
    • Management Team
    • Scientific Advisory Board
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Tear Sheet
    • Contacts
    • RSS News Feed
  • News / Events

  • Overview
  • Press Releases
  • In The News
  • IR Calendar

Soliton's Recent Positive Data Increases Potential Fibrotic Indications

Oct 29, 2019

Soliton Announces Positive Interim Clinical Trial Results with 27% Average Reduction in Scar Volume From Single Non-Invasive Treatment

Oct 25, 2019

Soliton to Announce Keloid Trial Data on October 25, 2019 and Host Webcast at 5:30PM ET to Discuss Results

Oct 21, 2019

Soliton's FDA Cleared RAP Device is Granted Two Additional Key Patents

Oct 15, 2019

Soliton Announces $6.25 Million Private Placement

Oct 10, 2019

Soliton to Announce Keloid and Hypertrophic Scar Clinical Trial Data on October 24, 2019

Oct 8, 2019

Soliton Announces Tattoo Technology Article Published in Medical Journal and Selected as Editor's Choice

Oct 3, 2019

Soliton Completes Keloid POC Clinical Trial Treatments

Oct 1, 2019

Soliton Announces Majority of Patients Treated in Pivotal Cellulite Trial; Expects All Patients Treated by November 2019

Sep 24, 2019

Soliton Begins Treatments In Proof-Of-Concept Trial For Keloid Scars

Sep 19, 2019
RSS
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...12

    To Follow Our Progress, Sign Up Here:

    Additional Information

    • Privacy Policy
    • Contact

    Social Media

    Links

    • About
    • Clinicians
    • Patients
    • Technology
    • Trials
    • Standards

    © 2021 Soliton Inc. All Rights Reserved, Soliton Inc.

      • Clinicians
      • Patients
      • RAP
      • Trials
      • Standards
      • Our Future
      • About
      • Investors